• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

Recent Advances in the Study of 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine (CAS: 156425-10-4)

The compound 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine (CAS: 156425-10-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide a comprehensive overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine as a key intermediate in the synthesis of various heterocyclic compounds. Its trifluoromethyl and chloro substituents contribute to its reactivity, making it a valuable building block in medicinal chemistry. Researchers have successfully utilized this compound in the development of novel kinase inhibitors, which show promise in targeting cancer-related pathways. The compound's ability to modulate protein-protein interactions has also been explored, opening new avenues for the treatment of neurodegenerative diseases.

In terms of synthetic methodologies, advancements have been made in the efficient production of 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine. A recent publication in the Journal of Medicinal Chemistry demonstrated an improved catalytic process that enhances yield and purity while reducing environmental impact. This breakthrough is particularly significant for scaling up production for preclinical and clinical studies.

Pharmacological evaluations have revealed interesting insights into the compound's mechanism of action. In vitro studies using cell-based assays have shown that derivatives of 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine exhibit selective inhibition against specific cancer cell lines, with minimal toxicity to normal cells. These findings were further supported by molecular docking studies, which identified potential binding sites on target proteins. Such results underscore the compound's potential as a lead candidate for anticancer drug development.

The safety profile of 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine has also been investigated in recent preclinical studies. Toxicological assessments in animal models have indicated favorable pharmacokinetic properties, including good oral bioavailability and acceptable metabolic stability. These characteristics make the compound suitable for further development as a pharmaceutical agent.

Looking ahead, researchers are exploring the potential of 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine in combination therapies and as part of drug delivery systems. Its chemical versatility allows for various modifications that could enhance its therapeutic index. Several pharmaceutical companies have included this compound in their pipelines, with some derivatives currently undergoing Phase I clinical trials for oncology indications.

In conclusion, 5-Chloro-3-(trifluoromethyl)benzene-1,2-diamine (CAS: 156425-10-4) represents a promising chemical entity in medicinal chemistry with diverse applications. The recent advancements in its synthesis, biological evaluation, and therapeutic potential highlight its importance in current drug discovery efforts. Continued research in this area is expected to yield novel therapeutic agents that could address unmet medical needs in various disease areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)